Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Brandt

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Archives of Pathology & Laboratory Medicine|November 8, 2002
Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic diseaseJohn T Brandt
The Journal of Molecular Diagnostics : JMD|May 15, 2012
Quantitative measurement of cell-free plasma DNA and applications for detecting tumor genetic variation and promoter methylation in a clinical settingSunil K Kadam, Mark Farmen, John T Brandt
Archives of Pathology & Laboratory Medicine|March 20, 2002
Laboratory diagnosis of dysfibrinogenemiaMark T Cunningham, John T Brandt, Michael Laposata, et al.
Analytical and Quantitative Cytology and Histology|June 22, 2006
Correlation between the papanicolaou stain and the Wright-Giemsa stain in body fluids: a quality assurance studyRichard R Gammon, Marzieh Kharazi, John T Brandt, et al.
Journal of Immunological Methods|July 22, 2005
Differential reactivity of anti-primate and anti-human secondary antibodies against human and monkey immunoglobulins: implications for determining the sensitivity of immunogenicity assaysJames S Bourdage, John T Brandt, Thomas N Lee, et al.
Archives of Pathology & Laboratory Medicine|August 1, 2013
D-dimer: simple test, tough problemsJohn D Olson, Mark T Cunningham, Russell A Higgins, et al.
Platelets|September 1, 2007
Clopidogrel poor responders: an objective definition based on Bayesian classificationGovinda J Weerakkody, John T Brandt, Christopher D Payne, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 19, 2007
Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysisGovinda J Weerakkody, Joseph A Jakubowski, John T Brandt, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 2, 2005
Effect of double antigen bridging immunoassay format on antigen coating concentration dependence and implications for designing immunogenicity assays for monoclonal antibodiesJames S Bourdage, Thomas N Lee, J Michael Taylor, et al.
Platelets|June 14, 2006
Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humansFumitoshi Asai, Joseph A Jakubowski, Hideo Naganuma, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Archives of Pathology & Laboratory Medicine|November 8, 2002
Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic diseaseJohn T Brandt
The Journal of Molecular Diagnostics : JMD|May 15, 2012
Quantitative measurement of cell-free plasma DNA and applications for detecting tumor genetic variation and promoter methylation in a clinical settingSunil K Kadam, Mark Farmen, John T Brandt
Archives of Pathology & Laboratory Medicine|March 20, 2002
Laboratory diagnosis of dysfibrinogenemiaMark T Cunningham, John T Brandt, Michael Laposata, et al.
Analytical and Quantitative Cytology and Histology|June 22, 2006
Correlation between the papanicolaou stain and the Wright-Giemsa stain in body fluids: a quality assurance studyRichard R Gammon, Marzieh Kharazi, John T Brandt, et al.
Journal of Immunological Methods|July 22, 2005
Differential reactivity of anti-primate and anti-human secondary antibodies against human and monkey immunoglobulins: implications for determining the sensitivity of immunogenicity assaysJames S Bourdage, John T Brandt, Thomas N Lee, et al.
Archives of Pathology & Laboratory Medicine|August 1, 2013
D-dimer: simple test, tough problemsJohn D Olson, Mark T Cunningham, Russell A Higgins, et al.
Platelets|September 1, 2007
Clopidogrel poor responders: an objective definition based on Bayesian classificationGovinda J Weerakkody, John T Brandt, Christopher D Payne, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 19, 2007
Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysisGovinda J Weerakkody, Joseph A Jakubowski, John T Brandt, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 2, 2005
Effect of double antigen bridging immunoassay format on antigen coating concentration dependence and implications for designing immunogenicity assays for monoclonal antibodiesJames S Bourdage, Thomas N Lee, J Michael Taylor, et al.
Platelets|June 14, 2006
Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humansFumitoshi Asai, Joseph A Jakubowski, Hideo Naganuma, et al.
Pageof 4